Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Porcine vaccinations are showing some intriguing tendencies. Pig farming modifications, disease prevention, and food safety values drive these developments. Veterinarians, pork producers, and vaccine manufacturers must grasp these market patterns to optimize pig health and productivity.
The pig industry is booming because more people desire protein-rich diets. As bacon remains a valuable source of animal energy, pigs require excellent treatments to be healthy and prevent disease.
New hog illnesses influence pig vaccination sales. African Swine Fever (ASF) and Porcine Epidemic Diarrhea Virus (PEDV) demonstrate the need for new vaccinations to address emerging pig farm issues.
New technologies are altering pig vaccination production. New genetics and genomic technologies are improving medical efficacy and targeting. These modifications help prevent illnesses and make pigs healthier.
Pig vaccinations are increasingly focused on protection. Stopping disease introduction and spread in pig communities is crucial to their health. Pig vaccinations are crucial to pork growers' security strategy.
Knowing more about viral infections affects pig vaccine development. Animal-to-human illnesses like influenza are gaining attention. Pig vaccines protect communities and reduce zoonotic illness transmission.
Globalization in pig farming affects pig medication sales. As pig farms grow increasingly interconnected, illnesses may spread across nations. This development requires drugs that can address particular pig farming issues.
Combination vaccinations are increasing in pig health management. Combination vaccinations prevent many illnesses with one injection, making immunization regimens simpler and less traumatic for pigs. This tendency helps prevent disease transmission.
Following laws and prioritizing vaccination safety are crucial in the pig vaccine business. To fulfill regulatory regulations, vaccine companies are investing in research and development to ensure their medicines are safe, effective, and approved.
Pig farmers are prioritizing genetic preservation and disease tolerance. Selective breeding aims to generate disease-resistant pigs. Vaccinations and this strategy provide a more comprehensive disease-free pig farm plan.
Digitalization is altering how vets deliver and monitor pig medications. Digital solutions simplify record-keeping, shot scheduling, and real-time pig health monitoring. This tendency makes massive pig farm immunization programs more effective and trackable.
When public and private sectors produce vaccines together, new ideas emerge. Public-private partnership shares resources and expertise to accelerate pig medical research and development. Successful drugs are launched faster with this cooperative approach.
Porcine Vaccines Market Highlights:
Global Porcine Vaccines Market Overview
Porcine Vaccines Market Size was valued at USD 1.79 Billion in 2023. The Global Porcine Vaccines industry is projected to grow from USD 1.92 Billion in 2024 to USD 3.04 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.27% during the forecast period (2024 - 2032).
Industry News in Porcine Vaccines Market
June 2024: Boehringer Ingelheim has introduced the Ingelvac® PRRSFLEX vaccine, an advanced adjuvant technology designed to enhance immune response and provide extended protection against multiple PRRS virus strains, offering improved efficacy and safety in field conditions.
January 2024:Ceva Santé Animale has introduced the Vaxxitek® HVT+IBR marker vaccine for swine, providing protection against PRRS and other common porcine diseases. The vaccine uses a recombinant virus vector platform, enhancing herd health management and vaccine technology advancement.
The porcine vaccine denotes an administrative and clinical drug that helps improve swine health. These vaccines help to protect from pathogens, deadly viruses and bacteria. Due to vaccines, widespread diseases such as swine influenza, diarrhoea, and respiratory syndrome have been reduced.
The increase in the commonness of diseases in swine all over the globe acts as one of the main factors which are operating the growth of the porcine vaccines market. The continuous invention in the market to fulfil the customer demand and the rise in initiatives by the government to support stages of development of vaccines increase the market growth. The increasing focus on delivering vaccination services to properly use the swine vaccines to deal with bacteria or viruses further influences market growth. Moreover, the technological development, rise in population and increase in the number of generic drug producers positively impact the porcine vaccines market. Furthermore, the special designation from the regulatory authority extends profitable opportunities to the main market players in the predicted period of 2022 to 2029. The covid-19 pandemic had an important impact on the market. Considering this global challenge, the pharmaceutical industry has extended its research at an extraordinary pace. For example, the research and development unit of Boehringer Ingelheim Animal Health business was renamed Animal Health Global Innovation. It was given a new administrative structure based on disease and a system-centred R&D approach. This allows the company to bring modernisations in treatment and preventive veterinary therapies to the market.
Porcine Vaccines Market Segment Insights
The porcine vaccines market has been segmented into type, disease indication, and end user.
Porcine Vaccines Type Insights
By type, the market has been segmented into Inactivated vaccines, Live attenuated vaccines, Toxoid vaccines, Recombinant vaccines, Conjugate vaccines, DNA vaccines.
Porcine Vaccines Disease Indication Insights
On the basis of disease indication, the market has been segmented into PED (Porcine Epidemic Diarrhea), PRRS (Porcine Reproductive & Respiratory Syndrome), Swine influenza, Aujeszky's disease (AD), Porcine Circovirus Associated Disease (PCVAD) and others.
Porcine Vaccines End-User Insights
The market, by end user, has been segmented into Veterinary Hospitals and Hog Production Farm.
Porcine Vaccines Regional Insights
The porcine vaccines market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The porcine vaccines market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.
The European porcine vaccines market has been segmented into Western Europe and Eastern Europe. The Western Europe porcine vaccines market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The porcine vaccines market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The porcine vaccines market in the Middle East & Africa has been segmented into the Middle East and Africa.
Regional Market Summary
Geographically, the Americas is anticipated to dominate the global porcine vaccines market owing to the rise in number of pig farms and rise in swine diseases such as PED (Porcine Epidemic Diarrhea), PRRS (Porcine Reproductive & Respiratory Syndrome), swine influenza etc. Moreover, rapid increase in contract farming and independent farming for pig cultivation is driving the growth of this market in this region. According to a report from National Hog Farmer, there were 71.7 million pigs in US hog farms as of June 2016.
Europe is expected to hold the second largest position in the global porcine vaccines market. The market growth in this region is attributed to increasing number of production units for swine and high consumption of pork meat.
The porcine vaccines market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to initiatives by various government agencies, animal associations, and high growth opportunities for major key players for setting up their vaccine manufacturing plants in this region.
The Middle East & Africa has the lowest share of the global porcine market. Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the animal care sector.
Porcine Vaccines Market, by Key Players
- Bayer AG
- Bimeda, Inc.
- Boehringer Ingelheim International GmbH
- Ceva Sante Animale
- Eli Lilly and Company
- Merck & Co., Inc.
- Sanofi S.A.
- Vetoquinol S.A.
- Zoetis, Inc.
- PBS Animal Health
- Aptimmune
Porcine Vaccines Market Segmentation
Porcine Vaccines Type Outlook
- Inactivated vaccines
- Live attenuated vaccines
- Toxoid vaccines
- Recombinant vaccines
- Conjugate vaccines
- DNA vaccines
Porcine Vaccines Disease Indication Outlook
- PED (Porcine Epidemic Diarrhea)
- PRRS (Porcine Reproductive & Respiratory Syndrome)
- Swine influenza
- Aujeszky's disease (AD)
- Porcine Circovirus Associated Disease (PCVAD)
- Others
Porcine Vaccines End-user Outlook
- Veterinary Hospitals
- Hog Production Farm
Porcine Vaccines Regional Outlook
- Americas
- North America
- US
- Canada
- Latin America
- North America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Western Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- The Middle East & Africa
- Middle East
- Africa
Recent Development
In the year 2021
The vaccine was created together and manufactured using CrisBio. This improved the rate of vaccine sales in the market.
Intended Audience
- Porcine vaccines manufacturers
- Porcine vaccines suppliers
- Private research laboratories
- Research and development (R&D) companies
- Market research and consulting service providers
- Government research laboratories
- Contract manufacturing organizations
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
